Sildenafil Citrate , ≥98%(HPLC) , 171599-83-0
Synonym(s):
1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate salt;5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[5,4-e]pyrimidin-7-one citrate salt;Revatio;Sildenafil citrate salt;UK-92,480
CAS NO.:171599-83-0
Empirical Formula: C28H38N6O11S
Molecular Weight: 666.7
MDL number: MFCD02102122
EINECS: 200-659-6
Pack Size | Price | Stock | Quantity |
25MG | RMB23.20 | In Stock |
|
100MG | RMB39.20 | In Stock |
|
500MG | RMB63.20 | In Stock |
|
1g | RMB79.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 187-189°C |
storage temp. | 2-8°C |
solubility | DMSO: >20mg/mL |
form | white powder |
color | White |
Water Solubility | 3.488g/L(temperature not stated) |
Merck | 14,8489 |
BCS Class | 1 |
Stability: | Store in Freezer |
InChIKey | DEIYFTQMQPDXOT-UHFFFAOYSA-N |
SMILES | C1(=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1)C1=NC(C2N(N=C(CCC)C=2N1)C)=O.C(O)(C(=O)O)(CC(=O)O)CC(=O)O |
CAS DataBase Reference | 171599-83-0(CAS DataBase Reference) |
Description and Uses
Sildenafil is a potent inhibitor of phosphodiesterase 5 (PDE5) with IC50 values of 3.6 and 3 nM for PDE5 activity in isolated rabbit platelets and human corpus cavernosum, respectively. It is selective for PDE5 over PDE1 and PDE3 (IC50s = 0.26 and 65 μM, respectively). Sildenafil reverses glucose-induced decreases in angiopoietin 1 (ANG1) expression and reduction of capillary-like tube formation by mouse dermal endothelial cells in vitro and increases the number of functional blood vessels and regional blood flow in the sciatic nerve in a db/db mouse model of diabetic peripheral neuropathy. It increases the ratio of maximum intracavernosal pressure to mean arterial blood pressure (ICP/MAP), a measure of erectile function, in castrated rats when administered at a dose of 20 mg/kg per day. Sildenafil (0.5 mg/kg) also reduces cardiac arrest and resuscitation-induced increases in angiotensin II , angiotensin converting enzyme (ACE), ACE2, and various angiotensin receptors and increases survival in a porcine model of ischemia/reperfusion injury. Formulations containing sildenafil have been used in the treatment of erectile dysfunction, pulmonary arterial hypertension, and high-altitude pulmonary edema associated with altitude sickness.
Sildenafil citrate is an orally active selective type 5 cgmp phosphodiesterase inhibitor that is used in the treatment of erectile dysfunction and primary pulmonary hypertension.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319-H335 |
Precautionary statements | P305+P351+P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 36 |
WGK Germany | 3 |
RTECS | TL4284390 |
HS Code | 2933595960 |